Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia

Petra Miketova, Kris Kaemingk, Marilyn Hockenberry, Alice E Pasvogel, John Hutter, Kevin Krull, Ida M Moore

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Central nervous system (CNS) treatment contributes to improved long-term disease-free survival from childhood acute lymphoblastic leukemia (ALL) by sigificantly decreasing the rate of disease relapse. Methotrexate (MTX), a drug commonly used for CNS treatment, has been associated with cognitive and academic problems, white-matter changes, perfusion defects, and brain atrophy. This study investigated oxidative stress as a possible mechanism of chemotherapy-induced CNS injury. Unoxidized and oxidized components of phosphatidylcholine (PC), the most prevalent phospholipid in CNS cellular membranes, were measured in cerebral spinal fluid (CSF) samples obtained from 21 children diagnosed with low- (n = 7), standard- (n = 7), or high- (n = 7) risk ALL. Children with high-risk ALL received the most MTX, especially during the most intensive phase of treatment (consolidation). Phospholipids were extracted from CSF samples obtained at diagnosis and during the induction, consolidation, and continuation treatment phases. Unoxidized and oxidized PC were measured by normal-phase high-performance liquid chromatography at 2 ultraviolet wavelengths (206 and 234 nm, respectively). Data were analyzed by 2-way repeated-measures analysis of variance. Results support the hypotheses that the highest levels of oxidized PC would be observed during the most intensive phase of ALL therapy and in the high-risk ALL group. Findings provide preliminary evidence for chemotherapy-induced oxidative stress in CNS membrane phospholipids.

Original languageEnglish (US)
Pages (from-to)187-195
Number of pages9
JournalBiological Research for Nursing
Volume6
Issue number3
DOIs
StatePublished - Jan 2005

Fingerprint

Phosphatidylcholines
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Central Nervous System
Phospholipids
Methotrexate
Oxidative Stress
Nervous System Trauma
Therapeutics
Drug Therapy
Membranes
Disease-Free Survival
Atrophy
Analysis of Variance
Perfusion
High Pressure Liquid Chromatography
Recurrence
Brain
Pharmaceutical Preparations

Keywords

  • Childhood leukemia
  • Lipid peroxidation
  • Methotrexate
  • Oxidative stress
  • Phosphatidylcholine

ASJC Scopus subject areas

  • Research and Theory

Cite this

Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia. / Miketova, Petra; Kaemingk, Kris; Hockenberry, Marilyn; Pasvogel, Alice E; Hutter, John; Krull, Kevin; Moore, Ida M.

In: Biological Research for Nursing, Vol. 6, No. 3, 01.2005, p. 187-195.

Research output: Contribution to journalArticle

Miketova, Petra ; Kaemingk, Kris ; Hockenberry, Marilyn ; Pasvogel, Alice E ; Hutter, John ; Krull, Kevin ; Moore, Ida M. / Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia. In: Biological Research for Nursing. 2005 ; Vol. 6, No. 3. pp. 187-195.
@article{be47e4aa0e73477b85bf032348f8e98f,
title = "Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia",
abstract = "Central nervous system (CNS) treatment contributes to improved long-term disease-free survival from childhood acute lymphoblastic leukemia (ALL) by sigificantly decreasing the rate of disease relapse. Methotrexate (MTX), a drug commonly used for CNS treatment, has been associated with cognitive and academic problems, white-matter changes, perfusion defects, and brain atrophy. This study investigated oxidative stress as a possible mechanism of chemotherapy-induced CNS injury. Unoxidized and oxidized components of phosphatidylcholine (PC), the most prevalent phospholipid in CNS cellular membranes, were measured in cerebral spinal fluid (CSF) samples obtained from 21 children diagnosed with low- (n = 7), standard- (n = 7), or high- (n = 7) risk ALL. Children with high-risk ALL received the most MTX, especially during the most intensive phase of treatment (consolidation). Phospholipids were extracted from CSF samples obtained at diagnosis and during the induction, consolidation, and continuation treatment phases. Unoxidized and oxidized PC were measured by normal-phase high-performance liquid chromatography at 2 ultraviolet wavelengths (206 and 234 nm, respectively). Data were analyzed by 2-way repeated-measures analysis of variance. Results support the hypotheses that the highest levels of oxidized PC would be observed during the most intensive phase of ALL therapy and in the high-risk ALL group. Findings provide preliminary evidence for chemotherapy-induced oxidative stress in CNS membrane phospholipids.",
keywords = "Childhood leukemia, Lipid peroxidation, Methotrexate, Oxidative stress, Phosphatidylcholine",
author = "Petra Miketova and Kris Kaemingk and Marilyn Hockenberry and Pasvogel, {Alice E} and John Hutter and Kevin Krull and Moore, {Ida M}",
year = "2005",
month = "1",
doi = "10.1177/1099800404271916",
language = "English (US)",
volume = "6",
pages = "187--195",
journal = "Biological Research for Nursing",
issn = "1099-8004",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia

AU - Miketova, Petra

AU - Kaemingk, Kris

AU - Hockenberry, Marilyn

AU - Pasvogel, Alice E

AU - Hutter, John

AU - Krull, Kevin

AU - Moore, Ida M

PY - 2005/1

Y1 - 2005/1

N2 - Central nervous system (CNS) treatment contributes to improved long-term disease-free survival from childhood acute lymphoblastic leukemia (ALL) by sigificantly decreasing the rate of disease relapse. Methotrexate (MTX), a drug commonly used for CNS treatment, has been associated with cognitive and academic problems, white-matter changes, perfusion defects, and brain atrophy. This study investigated oxidative stress as a possible mechanism of chemotherapy-induced CNS injury. Unoxidized and oxidized components of phosphatidylcholine (PC), the most prevalent phospholipid in CNS cellular membranes, were measured in cerebral spinal fluid (CSF) samples obtained from 21 children diagnosed with low- (n = 7), standard- (n = 7), or high- (n = 7) risk ALL. Children with high-risk ALL received the most MTX, especially during the most intensive phase of treatment (consolidation). Phospholipids were extracted from CSF samples obtained at diagnosis and during the induction, consolidation, and continuation treatment phases. Unoxidized and oxidized PC were measured by normal-phase high-performance liquid chromatography at 2 ultraviolet wavelengths (206 and 234 nm, respectively). Data were analyzed by 2-way repeated-measures analysis of variance. Results support the hypotheses that the highest levels of oxidized PC would be observed during the most intensive phase of ALL therapy and in the high-risk ALL group. Findings provide preliminary evidence for chemotherapy-induced oxidative stress in CNS membrane phospholipids.

AB - Central nervous system (CNS) treatment contributes to improved long-term disease-free survival from childhood acute lymphoblastic leukemia (ALL) by sigificantly decreasing the rate of disease relapse. Methotrexate (MTX), a drug commonly used for CNS treatment, has been associated with cognitive and academic problems, white-matter changes, perfusion defects, and brain atrophy. This study investigated oxidative stress as a possible mechanism of chemotherapy-induced CNS injury. Unoxidized and oxidized components of phosphatidylcholine (PC), the most prevalent phospholipid in CNS cellular membranes, were measured in cerebral spinal fluid (CSF) samples obtained from 21 children diagnosed with low- (n = 7), standard- (n = 7), or high- (n = 7) risk ALL. Children with high-risk ALL received the most MTX, especially during the most intensive phase of treatment (consolidation). Phospholipids were extracted from CSF samples obtained at diagnosis and during the induction, consolidation, and continuation treatment phases. Unoxidized and oxidized PC were measured by normal-phase high-performance liquid chromatography at 2 ultraviolet wavelengths (206 and 234 nm, respectively). Data were analyzed by 2-way repeated-measures analysis of variance. Results support the hypotheses that the highest levels of oxidized PC would be observed during the most intensive phase of ALL therapy and in the high-risk ALL group. Findings provide preliminary evidence for chemotherapy-induced oxidative stress in CNS membrane phospholipids.

KW - Childhood leukemia

KW - Lipid peroxidation

KW - Methotrexate

KW - Oxidative stress

KW - Phosphatidylcholine

UR - http://www.scopus.com/inward/record.url?scp=16644366977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644366977&partnerID=8YFLogxK

U2 - 10.1177/1099800404271916

DO - 10.1177/1099800404271916

M3 - Article

C2 - 15583359

AN - SCOPUS:16644366977

VL - 6

SP - 187

EP - 195

JO - Biological Research for Nursing

JF - Biological Research for Nursing

SN - 1099-8004

IS - 3

ER -